Skip to content

CHINA PHARMA HOLDINGS, INC.: 10-Q filed 2019-11-14

What CHINA PHARMA HOLDINGS, INC. reported in its quarterly report filed 2019-11-14 (fiscal Q3 2019): 45 published measures, 128 facts as tagged in accession 0001213900-19-023467.

This filing

Form
10-Q (quarterly report)
Filed
2019-11-14
Fiscal period
fiscal Q3 2019
Accession
0001213900-19-023467 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA PHARMA HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-09-3039,900,631USD
At 2018-12-3145,377,325USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-09-3012,543,832USD
At 2018-12-3115,178,550USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-09-3027,356,799USD
At 2019-06-3028,967,642USD
At 2019-03-3130,616,909USD
At 2018-12-3130,198,775USD
At 2018-09-3037,633,123USD
At 2018-06-3041,025,066USD
At 2018-03-3144,451,898USD
At 2017-12-3143,071,302USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-09-30761,606USD
At 2018-12-311,186,587USD
At 2018-09-30667,629USD
At 2017-12-312,030,214USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-700,954USD92
2019-01-01 to 2019-09-30-1,956,788USD273
2018-07-01 to 2018-09-30-1,856,519USD92
2018-01-01 to 2018-09-30-3,158,048USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-09-301,403,678USD273
2018-01-01 to 2018-09-301,007,688USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-09-3085,739USD273
2018-01-01 to 2018-09-3033,332USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-07-01 to 2019-09-302,376,844USD92
2019-01-01 to 2019-09-307,875,525USD273
2018-07-01 to 2018-09-302,298,472USD92
2018-01-01 to 2018-09-309,087,867USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-1,723,784USD273
2018-01-01 to 2018-09-30-2,303,410USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-85,739USD273
2018-01-01 to 2018-09-30-33,332USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-09-30-7,227,146USD
At 2018-12-31-5,270,358USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-160,485USD92
2018-01-01 to 2018-09-30-111,910USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-09-3016,697,256USD
At 2018-12-3119,294,379USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-645,204USD92
2019-01-01 to 2019-09-30-1,732,380USD273
2018-07-01 to 2018-09-30-1,931,434USD92
2018-01-01 to 2018-09-30-2,936,524USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-09-306,239,245USD
At 2018-12-318,746,916USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-07-01 to 2019-09-3067,590USD92
2019-01-01 to 2019-09-30251,624USD273
2018-07-01 to 2018-09-30101,683USD92
2018-01-01 to 2018-09-30361,365USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-09-309,608,966USD
At 2018-12-3110,051,456USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2019-09-30211,491USD
At 2018-12-31266,443USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-07-01 to 2019-09-301,017,963USD92
2019-01-01 to 2019-09-302,925,217USD273
2018-07-01 to 2018-09-302,443,979USD92
2018-01-01 to 2018-09-305,082,250USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-09-303,973,373USD
At 2018-12-315,054,975USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30372,759USD92
2019-01-01 to 2019-09-301,192,837USD273
2018-07-01 to 2018-09-30512,545USD92
2018-01-01 to 2018-09-302,145,726USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-07-01 to 2019-09-302,004,085USD92
2019-01-01 to 2019-09-306,682,688USD273
2018-07-01 to 2018-09-301,785,927USD92
2018-01-01 to 2018-09-306,942,141USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-07-01 to 2019-09-3039,716USD92
2019-01-01 to 2019-09-30175,642USD273
2018-07-01 to 2018-09-3062,059USD92
2018-01-01 to 2018-09-30107,946USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-09-3043,579,557shares
At 2018-12-3143,579,557shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-09-3023,590,204USD
At 2018-12-3123,590,204USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-09-3010,950,161USD
At 2018-12-3111,835,349USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-09-30157,177USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-09-30159,948USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2019-09-304,241,542USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2019-09-3036,064,077USD
At 2018-12-3137,008,952USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2019-09-3019,366,821USD
At 2018-12-3117,714,573USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2019-09-30211,491USD
At 2018-12-31266,443USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-09-30140,753USD
At 2018-12-31310,804USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-700,954USD92
2019-01-01 to 2019-09-30-1,956,788USD273
2018-07-01 to 2018-09-30-2,017,004USD92
2018-01-01 to 2018-09-30-3,269,958USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-700,954USD92
2019-04-01 to 2019-06-30-838,103USD91
2019-01-01 to 2019-03-31-417,731USD90
2018-07-01 to 2018-09-30-1,856,519USD92
2018-04-01 to 2018-06-30-1,008,049USD91
2018-01-01 to 2018-03-31-293,480USD90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-1,610,843USD92
2019-01-01 to 2019-09-30-2,841,976USD273
2018-07-01 to 2018-09-30-3,391,943USD92
2018-01-01 to 2018-09-30-5,438,179USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30333,833USD92
2019-01-01 to 2019-09-301,097,200USD273
2018-07-01 to 2018-09-30327,161USD92
2018-01-01 to 2018-09-301,172,314USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-07-01 to 2019-09-30677,395USD92
2019-01-01 to 2019-09-302,212,731USD273
2018-07-01 to 2018-09-30942,555USD92
2018-01-01 to 2018-09-302,405,396USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2019-01-01 to 2019-09-302,261,800USD273
2018-01-01 to 2018-09-302,499,114USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2019-07-01 to 2019-09-308,536USD92
2019-01-01 to 2019-09-3049,070USD273
2018-07-01 to 2018-09-3026,861USD92
2018-01-01 to 2018-09-3093,718USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-55,750USD92
2019-01-01 to 2019-09-30-224,408USD273
2018-07-01 to 2018-09-30-85,570USD92
2018-01-01 to 2018-09-30-333,434USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2018-01-01 to 2018-09-3069,614USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-09-30241,465USD273
2018-01-01 to 2018-09-30351,206USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-09-300USD92
2019-01-01 to 2019-09-300USD273
2018-07-01 to 2018-09-300USD92
2018-01-01 to 2018-09-300USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-1,436,878USD273
2018-01-01 to 2018-09-30-471,995USD273

Inspect the source

Entity
CHINA PHARMA HOLDINGS, INC. / CIK 0001106644
Captured
SEC response SHA-256
ad45dffd15d0f5a098ab8b6912816a8b1b845b1d791781ea412833d3178873c0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001106644.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))